Jun-ichi Kawada1, Yuka Torii1, Yoshihiko Kawano1, Michio Suzuki1, Yasuko Kamiya1, Tomomi Kotani2, Fumitaka Kikkawa2, Hiroshi Kimura3, Yoshinori Ito4. 1. Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. 2. Department of Obstetrics and Genecology, Nagoya University Graduate School of Medicine,Nagoya, Japan. 3. Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan. 4. Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: yoshi-i@med.nagoya-u.ac.jp.
Abstract
BACKGROUND: Congenital cytomegalovirus (CMV) infection is the most common non-genetic cause of sensorineural hearing loss (SNHL) in children. However, congenital SNHL without other clinical abnormalities is rarely diagnosed as CMV-related in early infancy. OBJECTIVES: The aim of this study was to identify and treat patients with congenital CMV-related SNHL or CMV-related clinical abnormalities other than SNHL. The association between CMV load and SNHL was also evaluated. STUDY DESIGN: Newborns who had abnormal hearing screening results or other clinical abnormalities were screened for congenital CMV infection by PCR of saliva or urine specimens, and identified infected patients were treated with valganciclovir (VGCV) for 6 weeks. The CMV load of patients with or without SNHL was compared at regular intervals during as well as after VGCV treatment. RESULTS: Of 127 infants with abnormal hearing screening results, and 31 infants with other clinical abnormalities, CMV infection was identified in 6 and 3 infants, respectively. After VGCV treatment, 1 case had improved hearing but the other 5 SNHL cases had little or no improvement. Among these 9 patients with or without SNHL at 1 year of age, there was no significant difference in CMV blood or urine load at diagnosis, but both were significantly higher in patients with SNHL during VGCV treatment. CONCLUSIONS: Selective CMV screening of newborns having an abnormal hearing screening result would be a reasonable strategy for identification of symptomatic congenital CMV infection. Prolonged detection of CMV in blood could be a risk factor for SNHL.
BACKGROUND:Congenital cytomegalovirus (CMV) infection is the most common non-genetic cause of sensorineural hearing loss (SNHL) in children. However, congenital SNHL without other clinical abnormalities is rarely diagnosed as CMV-related in early infancy. OBJECTIVES: The aim of this study was to identify and treat patients with congenital CMV-related SNHL or CMV-related clinical abnormalities other than SNHL. The association between CMV load and SNHL was also evaluated. STUDY DESIGN: Newborns who had abnormal hearing screening results or other clinical abnormalities were screened for congenital CMV infection by PCR of saliva or urine specimens, and identified infectedpatients were treated with valganciclovir (VGCV) for 6 weeks. The CMV load of patients with or without SNHL was compared at regular intervals during as well as after VGCV treatment. RESULTS: Of 127 infants with abnormal hearing screening results, and 31 infants with other clinical abnormalities, CMV infection was identified in 6 and 3 infants, respectively. After VGCV treatment, 1 case had improved hearing but the other 5 SNHL cases had little or no improvement. Among these 9 patients with or without SNHL at 1 year of age, there was no significant difference in CMV blood or urine load at diagnosis, but both were significantly higher in patients with SNHL during VGCV treatment. CONCLUSIONS: Selective CMV screening of newborns having an abnormal hearing screening result would be a reasonable strategy for identification of symptomatic congenital CMV infection. Prolonged detection of CMV in blood could be a risk factor for SNHL.
Authors: Concetta Marsico; Immaculada Aban; Huichien Kuo; Scott H James; Pablo J Sanchez; Amina Ahmed; Ravit Arav-Boger; Marian G Michaels; Negar Ashouri; Janet A Englund; Benjamin Estrada; Richard F Jacobs; José R Romero; Sunil K Sood; Suzanne Whitworth; Penelope M Jester; Richard J Whitley; David W Kimberlin Journal: J Infect Dis Date: 2019-04-16 Impact factor: 5.226
Authors: Shannon A Ross; Amina Ahmed; April L Palmer; Marian G Michaels; Pablo J Sánchez; Audra Stewart; David I Bernstein; Kristina Feja; Karen B Fowler; Suresh B Boppana Journal: J Pediatr Date: 2017-02-22 Impact factor: 4.406
Authors: Christine D'Aguillo; Sara Bressler; Denise Yan; Rahul Mittal; Robert Fifer; Susan H Blanton; Xuezhong Liu Journal: Int J Audiol Date: 2019-07-02 Impact factor: 2.117